- Home
- ONCY vs CNVS Comparison
ONCY vs CNVS Comparison
Compare ONCY & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- CNVS
- Stock Information
- Founded
- ONCY 1998
- CNVS 2000
- Country
- ONCY Canada
- CNVS United States
- Employees
- ONCY N/A
- CNVS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- CNVS Consumer Electronics/Video Chains
- Sector
- ONCY Health Care
- CNVS Consumer Discretionary
- Exchange
- ONCY Nasdaq
- CNVS Nasdaq
- Market Cap
- ONCY 89.7M
- CNVS 102.4M
- IPO Year
- ONCY 1999
- CNVS 2003
- Fundamental
- Price
- ONCY $1.06
- CNVS $5.18
- Analyst Decision
- ONCY Strong Buy
- CNVS Buy
- Analyst Count
- ONCY 5
- CNVS 1
- Target Price
- ONCY $5.00
- CNVS $10.00
- AVG Volume (30 Days)
- ONCY 681.0K
- CNVS 314.3K
- Earning Date
- ONCY 08-08-2025
- CNVS 08-14-2025
- Dividend Yield
- ONCY N/A
- CNVS N/A
- EPS Growth
- ONCY N/A
- CNVS N/A
- EPS
- ONCY N/A
- CNVS 0.13
- Revenue
- ONCY N/A
- CNVS $80,173,000.00
- Revenue This Year
- ONCY N/A
- CNVS $1.28
- Revenue Next Year
- ONCY N/A
- CNVS N/A
- P/E Ratio
- ONCY N/A
- CNVS $38.03
- Revenue Growth
- ONCY N/A
- CNVS 77.07
- 52 Week Low
- ONCY $0.33
- CNVS $0.72
- 52 Week High
- ONCY $1.53
- CNVS $7.39
- Technical
- Relative Strength Index (RSI)
- ONCY 54.04
- CNVS 47.65
- Support Level
- ONCY $0.95
- CNVS $5.00
- Resistance Level
- ONCY $1.07
- CNVS $5.39
- Average True Range (ATR)
- ONCY 0.08
- CNVS 0.43
- MACD
- ONCY 0.01
- CNVS -0.03
- Stochastic Oscillator
- ONCY 81.89
- CNVS 44.85
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.